0001437749-18-019804.txt : 20181107
0001437749-18-019804.hdr.sgml : 20181107
20181107134221
ACCESSION NUMBER: 0001437749-18-019804
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20181107
DATE AS OF CHANGE: 20181107
EFFECTIVENESS DATE: 20181107
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Celcuity Inc.
CENTRAL INDEX KEY: 0001603454
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-287126
FILM NUMBER: 181165607
BUSINESS ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 450
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
BUSINESS PHONE: 763-392-0767
MAIL ADDRESS:
STREET 1: 16305 36TH AVENUE N
STREET 2: SUITE 450
CITY: MINNEAPOLIS
STATE: MN
ZIP: 55446
FORMER COMPANY:
FORMER CONFORMED NAME: Celcuity LLC
DATE OF NAME CHANGE: 20140324
D/A
1
primary_doc.xml
X0708
D/A
LIVE
0001603454
Celcuity Inc.
16305 36TH AVENUE NORTH
SUITE 100
MINNEAPOLIS
MN
MINNESOTA
55446
763-392-0123
DELAWARE
Celcuity LLC
Corporation
true
Brian
F.
Sullivan
16305 36th Avenue North
Suite 100
Minneapolis
MN
MINNESOTA
55446
Executive Officer
Director
Promoter
Lance
G.
Laing
16305 36th Avenue North
Suite 100
Minneapolis
MN
MINNESOTA
55446
Executive Officer
Director
Promoter
Vicky
Hahne
16305 36th Avenue North
Suite 100
Minneapolis
MN
MINNESOTA
55446
Executive Officer
Maureen
Cronin
16305 36th Avenue North
Suite 100
Minneapolis
MN
MINNESOTA
55446
Director
David
F.
Dalvey
16305 36th Avenue North
Suite 100
Minneapolis
MN
MINNESOTA
55446
Director
Richard
J.
Nigon
16305 36th Avenue North
Suite 100
Minneapolis
MN
MINNESOTA
55446
Director
Biotechnology
Decline to Disclose
- 06b
true
0001209191-17-059583
2017-05-05
true
true
true
The Convertible Promissory Notes were converted into equity securities and warrants. This Form D covers those issued warrants and their underlying equity securities.
false
0
Cedar Point Capital, LLC
145116
Cedar Point Capital, LLC
145116
4600 West 77th Street
Suite 375
Edina
MN
MINNESOTA
55435
IL
ILLINOIS
NY
NEW YORK
IN
INDIANA
CT
CONNECTICUT
MN
MINNESOTA
WI
WISCONSIN
AZ
ARIZONA
CA
CALIFORNIA
OR
OREGON
MT
MONTANA
NJ
NEW JERSEY
TX
TEXAS
FL
FLORIDA
NC
NORTH CAROLINA
PA
PENNSYLVANIA
ND
NORTH DAKOTA
MA
MASSACHUSETTS
false
2975746
2593305
382441
The Convertible Notes ($2,587,500) initially sold in this offering were converted into common stock and 40,868 warrant shares exer. at $9.50/share on 9-22-17. This filing covers the continuing offering of shares issuable upon exercise of the warrants.
false
38
258000
0
Represents amount paid upon the sale of Convertible Notes. The underlying offering is complete.
100000
true
false
Celcuity Inc.
/s/ Brian F. Sullivan
Brian F. Sullivan
Chief Executive Officer
2018-11-07